PGAM4 silencing inhibited glycolysis and chemoresistance to temozolomide in glioma cells
Sign Up to like & getrecommendations! Published in 2022 at "Cell Biology International"
DOI: 10.1002/cbin.11983
Abstract: Gliomas account for about 80% of malignant brain tumors. The incidence of a new brain tumor is 6.4 per 100,000 persons per year with an overall 5‐year survival rate of 33.4%. Regardless of the great… read more here.
Keywords: pgam4 silencing; glycolysis; glioma; viability proliferation ... See more keywords